Focusing on discoidin domain receptors in premalignant and malignant liver diseases

Area of Science:

• Oncology
• Hepatology
• Molecular Biology

Background:

• Discoidin domain receptors (DDRs), a class of receptor tyrosine kinases, are implicated in premalignant and malignant liver diseases.
• DDRs bind extracellular collagens and are typically minimally expressed in healthy liver tissue.

Purpose of the Study:

• To review the roles and mechanisms of DDR1 and DDR2 in the progression of premalignant and malignant liver diseases.
• To synthesize findings from preclinical in vitro and in vivo studies to elucidate DDR functions in liver cancer.
• To offer novel perspectives for liver cancer treatment strategies.

Main Methods:

• Comprehensive literature review of preclinical studies on DDR1 and DDR2 in liver disease models.
• Analysis of in vitro and in vivo experimental data.
• Synthesis of current understanding of DDR signaling pathways in liver pathology.

Main Results:

• DDR1 exhibits pro-inflammatory and pro-fibrotic effects, enhancing tumor cell invasion, migration, and liver metastasis.
• DDR2 may contribute to early-stage liver injury (prefibrotic) and plays distinct roles in chronic fibrosis and metastatic liver cancer.
• Differential roles of DDR1 and DDR2 highlight their complex involvement in liver disease pathogenesis.

Conclusions:

• DDRs are critical regulators in the development and progression of liver premalignancy and malignancy.
• Understanding DDR1 and DDR2 functions offers potential therapeutic targets for liver cancer.
• Further research into DDR signaling may accelerate the translation of findings into clinical applications for liver cancer treatment.